A Placebo-Controlled, Double-Blinded Study of Recombinant IFNγ in Dogs With Atopic Dermatitis

    August 2004 in “ Veterinary Dermatology ”
    Atsuko Hasegawa, Teiko Sakurai, T. Iwasaki
    Studysummary This study reported that canine recombinant IFNγ (KT‐100) significantly improved atopic dermatitis symptoms in dogs compared to placebo, and it appeared to be safe during the study period.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →